Project Grant R01DK141510
Award Date
9/20/24
Completion Date
5/31/29
Dollars Obligated
$2.2M
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
New York, NY 10029, USA
Similar Awards
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), focuses on developing improved therapies for chronic kidney disease (CKD) by blocking the sphingosine 1-phosphate (S1P) signaling pathway. The $616,104 award, with a period of performance from September 2024 to April 2028, aims to make the SPHK2 inhibitor and SPNS2 inhibitor compounds more...
This federal Project Grant award of $253,500.00 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant aims to develop state-of-the-art approaches to selectively target and degrade a mutant variant of the KLF1 transcription factor, which can lead to congenital dyserythropoietic anemia (CDA) when mutated. The research, summarized in two main aims, will...
This federal Project Grant award of $1,145,486 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to develop novel peripherally acting CB1 neutral antagonists for the treatment of diabetic kidney disease (DKD). The principal contractor, Makscientific LLC, a for-profit limited liability company, will design and synthesize analogs of the compound AM6588 to improve...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will fund research to systematically evaluate the molecular cascade involving Type 2 diabetes (T2D) effector genes, the transcription factors RFX3/6, and T2D-associated genetic variants in human islet cell generation, survival, and function. The $561,893 award, with a period of performance...
This $746,198 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research on the relationship between per- and polyfluoroalkyl substances (PFAS) exposure and diabetic kidney disease (DKD) in youth with type 2 diabetes. The award will leverage data from two existing NIDDK-funded longitudinal cohort studies to assess how PFAS exposure...
This $490,620 Project Grant was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant will fund research at the University of Pittsburgh to investigate the role of the unfolded protein response (UPR) in the development of acute kidney injury (AKI). The primary objectives are to: Determine the mechanism by which the PERK stress sensor within the UPR pathway...
This $531,999 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports research into the role of alternative splicing in diabetic kidney disease (DKD) at The Washington University. The key objectives are to: 1) Define and validate the spectrum of alternative splicing in DKD and response to sodium-glucose cotransporter 2 inhibitor (SGLT2i)...
The federal Project Grant award F31DK136312, totaling $128,286.00, was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant aims to uncover the underlying cellular mechanisms that contribute to the effects of free fatty acid-induced lipotoxicity in kidney tubular epithelial cells and the development of chronic kidney disease (CKD). The research will be...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $199,990 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to The Ohio State University. The grant supports research to investigate the role of the transcriptional corepressor CTBP2 as a metabolic sensor in acute kidney injury (AKI). The research aims to determine how CTBP2 activation and regulation contribute to renal epithelial cell dysfunction and...
This $142,902 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to uncover the mechanisms by which the regulatory GTPase protein ARL13B drives kidney cyst formation in polycystic kidney disease (PKD). The research, led by Dr. Van Sciver at Emory University, aims to identify the critical interactions between ARL13B and three key...